Contact Urticaria and Related Conditions: Clinical Review.

Area of Science:

• Dermatology
• Allergology
• Immunology

Background:

• Contact urticaria (CoU) presents as an immediate hypersensitivity reaction within minutes to an hour post-exposure.
• CoU is classified into non-immunologic (NI-CoU) and immunologic (I-CoU) forms, with I-CoU posing a risk for anaphylaxis.
• Both CoU types can be linked to protein contact dermatitis and CoU syndrome, and I-CoU patients may exhibit other type I allergic conditions.

Purpose of the Study:

• To provide a comprehensive review of contact urticaria.
• To detail triggers, diagnostic methodologies, and management strategies for CoU.
• To highlight the importance of early diagnosis and appropriate treatment for CoU and related conditions.

Main Methods:

• Review of existing literature on contact urticaria.
• Analysis of triggers for NI-CoU (low molecular weight chemicals) and I-CoU (proteins and chemicals via IgE-mediated hypersensitivity).
• Discussion of diagnostic tools including medical history, physical examination, imaging, skin tests, and in vitro assays.

Main Results:

• NI-CoU is primarily triggered by chemicals, whereas I-CoU involves IgE responses to proteins and chemicals.
• CoU is frequently underrecognized, emphasizing the need for improved diagnostic awareness.
• Management focuses on avoiding triggers, with antihistamines as first-line for I-CoU and omalizumab for severe cases.

Conclusions:

• Effective management of CoU requires accurate diagnosis and strict avoidance of identified triggers.
• Pharmacological interventions, including H1-antihistamines and potentially anti-IgE therapy, are crucial for symptom control.
• Patients at risk of anaphylaxis must be educated on emergency preparedness, including carrying an adrenaline auto-injector.